谭虹, 董豪坚. 联合降脂未能使有高心血管风险的2型糖尿病患者获益——ACCORD-Lipid研究的启示[J]. 循证医学, 2010, 10(6): 333-336. DOI: 10.3969/j.issn.1671-5144.2010.06.012
    引用本文: 谭虹, 董豪坚. 联合降脂未能使有高心血管风险的2型糖尿病患者获益——ACCORD-Lipid研究的启示[J]. 循证医学, 2010, 10(6): 333-336. DOI: 10.3969/j.issn.1671-5144.2010.06.012
    TAN Hong, DONG Hao-jian. Combination Lipid-Lowering Failed to Make High Cardiovascular Risk in Patients with Type 2 Diabetes Gain——ACCORD Lipid Research Enlightenment[J]. Journal of Evidence-Based Medicine, 2010, 10(6): 333-336. DOI: 10.3969/j.issn.1671-5144.2010.06.012
    Citation: TAN Hong, DONG Hao-jian. Combination Lipid-Lowering Failed to Make High Cardiovascular Risk in Patients with Type 2 Diabetes Gain——ACCORD Lipid Research Enlightenment[J]. Journal of Evidence-Based Medicine, 2010, 10(6): 333-336. DOI: 10.3969/j.issn.1671-5144.2010.06.012

    联合降脂未能使有高心血管风险的2型糖尿病患者获益——ACCORD-Lipid研究的启示

    Combination Lipid-Lowering Failed to Make High Cardiovascular Risk in Patients with Type 2 Diabetes Gain——ACCORD Lipid Research Enlightenment

    /

    返回文章
    返回